Search research articles
Contact Us
Filters
Showing results (71-80 of 79) with videos related to
Page
of 8
Sort By:
You have reached the last page of results.
This site can display upto 79 results.
Arthritis Research & Therapy
|
August 21, 2015
Treatment of systemic lupus erythematosus patients with the BAFF antagonist "peptibody" blisibimod (AMG 623/A-623): results from randomized, double-blind phase 1a and phase 1b trials
William Stohl, Joan T Merrill, R John Looney, et al.
RNA (New York, N.Y.)
|
February 2, 2012
Comprehensive evaluation of canonical versus Dicer-substrate siRNA in vitro and in vivo
Donald J Foster, Scott Barros, Rick Duncan, et al.
British Journal of Clinical Pharmacology
|
November 9, 2024
Population pharmacokinetics and exposure-response relationships of dostarlimab in primary advanced or recurrent endometrial cancer in part 1 of RUBY
Mita Kuchimanchi, Trine Lembrecht Jørgensen, Eva Hanze, et al.
Biotechnology Progress
|
November 23, 2012
Evaluation of exogenous siRNA addition as a metabolic engineering tool for modifying biopharmaceuticals
Seshu Tummala, Michael Titus, Lee Wilson, et al.
Autoimmunity
|
March 21, 2009
An antibody to IP-10 is a potent antagonist of cell migration in vitro and in vivo and does not affect disease in several animal models of inflammation
Fergus R Byrne, Aaron Winters, David Brankow, et al.
Indian Journal of Critical Care Medicine : Peer-Reviewed, Official Publication of Indian Society of Critical Care Medicine
|
June 28, 2021
Timing of Invasive Mechanical Ventilation and Mortality among Patients with Severe COVID-19-associated Acute Respiratory Distress Syndrome
Kapil G Zirpe, Anand M Tiwari, Sushma K Gurav, et al.
Journal of the American Chemical Society
|
December 2, 2014
Multivalent N-acetylgalactosamine-conjugated siRNA localizes in hepatocytes and elicits robust RNAi-mediated gene silencing
Jayaprakash K Nair, Jennifer L S Willoughby, Amy Chan, et al.
Nature Medicine
|
April 8, 2015
An RNAi therapeutic targeting antithrombin to rebalance the coagulation system and promote hemostasis in hemophilia
Alfica Sehgal, Scott Barros, Lacramioara Ivanciu, et al.
Cancer Immunology Research
|
June 28, 2023
AXL Inhibition Improves the Antitumor Activity of Chimeric Antigen Receptor T Cells
R Leo Sakemura, Mehrdad Hefazi, Michelle J Cox, et al.
Page
of 8
Search research articles
Search
Showing results (71-80 of 79) with videos related to
Sort By:
Page
of 8
You have reached the last page of results.
This site can display upto 79 results.
Arthritis Research & Therapy
|
August 21, 2015
Treatment of systemic lupus erythematosus patients with the BAFF antagonist "peptibody" blisibimod (AMG 623/A-623): results from randomized, double-blind phase 1a and phase 1b trials
William Stohl, Joan T Merrill, R John Looney, et al.
RNA (New York, N.Y.)
|
February 2, 2012
Comprehensive evaluation of canonical versus Dicer-substrate siRNA in vitro and in vivo
Donald J Foster, Scott Barros, Rick Duncan, et al.
British Journal of Clinical Pharmacology
|
November 9, 2024
Population pharmacokinetics and exposure-response relationships of dostarlimab in primary advanced or recurrent endometrial cancer in part 1 of RUBY
Mita Kuchimanchi, Trine Lembrecht Jørgensen, Eva Hanze, et al.
Biotechnology Progress
|
November 23, 2012
Evaluation of exogenous siRNA addition as a metabolic engineering tool for modifying biopharmaceuticals
Seshu Tummala, Michael Titus, Lee Wilson, et al.
Autoimmunity
|
March 21, 2009
An antibody to IP-10 is a potent antagonist of cell migration in vitro and in vivo and does not affect disease in several animal models of inflammation
Fergus R Byrne, Aaron Winters, David Brankow, et al.
Indian Journal of Critical Care Medicine : Peer-Reviewed, Official Publication of Indian Society of Critical Care Medicine
|
June 28, 2021
Timing of Invasive Mechanical Ventilation and Mortality among Patients with Severe COVID-19-associated Acute Respiratory Distress Syndrome
Kapil G Zirpe, Anand M Tiwari, Sushma K Gurav, et al.
Journal of the American Chemical Society
|
December 2, 2014
Multivalent N-acetylgalactosamine-conjugated siRNA localizes in hepatocytes and elicits robust RNAi-mediated gene silencing
Jayaprakash K Nair, Jennifer L S Willoughby, Amy Chan, et al.
Nature Medicine
|
April 8, 2015
An RNAi therapeutic targeting antithrombin to rebalance the coagulation system and promote hemostasis in hemophilia
Alfica Sehgal, Scott Barros, Lacramioara Ivanciu, et al.
Cancer Immunology Research
|
June 28, 2023
AXL Inhibition Improves the Antitumor Activity of Chimeric Antigen Receptor T Cells
R Leo Sakemura, Mehrdad Hefazi, Michelle J Cox, et al.
Page
of 8